Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CK-3773274 dose-finding study in symptomatic obstructive hypertrophic cardiomyopathy
2019-002785-12Phase 2Active
- Sponsor
- Cytokinetics
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypertrophic cardiomyopathy (HCM) comparing CK-3773274 with Placebo (2 arms). Started Dec 2019; status: active.
02
Drugs
aficamten
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on 2019-002785-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002785-12.